ProfileGDS4718 / 216080_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 66% 70% 68% 63% 69% 68% 63% 64% 66% 64% 70% 73% 73% 60% 62% 64% 63% 69% 59% 74% 67% 62% 60% 64% 69% 64% 61% 57% 63% 63% 65% 68% 63% 71% 73% 59% 65% 66% 73% 59% 60% 67% 75% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3298763
GSM549102patient 115, normal, homogenized [OPG study]6.5221966
GSM549104patient 119, normal, homogenized [OPG study]6.8980370
GSM549108patient 138, normal, homogenized [OPG study]6.6973968
GSM549119patient 077, normal, homogenized [OPG study]6.3004663
GSM549133patient 032, cancer, homogenized [OPG study]6.8340869
GSM549139patient 042, cancer, homogenized [OPG study]6.7379368
GSM549099patient 107, normal, homogenized [OPG study]6.3317763
GSM549109patient 139, normal, homogenized [OPG study]6.4425664
GSM549110patient 046, normal, homogenized [OPG study]6.5123466
GSM549114patient 063, normal, homogenized [OPG study]6.3641564
GSM549122patient 082, normal, homogenized [OPG study]6.899270
GSM549134patient 033, cancer, homogenized [OPG study]7.1467173
GSM549136patient 036, cancer, homogenized [OPG study]7.1845973
GSM549140patient 044, cancer, homogenized [OPG study]6.1172660
GSM549111patient 047, normal, homogenized [OPG study]6.2509662
GSM549113patient 057, normal, homogenized [OPG study]6.3719864
GSM549132patient 031, cancer, homogenized [OPG study]6.3381963
GSM549137patient 038, cancer, homogenized [OPG study]6.8201669
GSM549142patient 047, cancer, homogenized [OPG study]6.1783659
GSM549100patient 110, normal, homogenized [OPG study]7.194174
GSM549107patient 135, normal, homogenized [OPG study]6.6583367
GSM549115patient 068, normal, homogenized [OPG study]6.2497262
GSM549116patient 072, normal, homogenized [OPG study]6.1599260
GSM549120patient 078, normal, homogenized [OPG study]6.4125964
GSM549131patient 030, cancer, homogenized [OPG study]6.8527869
GSM549118patient 074, normal, homogenized [OPG study]6.4243764
GSM549129patient 027, cancer, homogenized [OPG study]6.2534761
GSM549123patient 088, normal, homogenized [OPG study]5.9636457
GSM549124patient 006, cancer, homogenized [OPG study]6.3252763
GSM549126patient 015, cancer, homogenized [OPG study]6.2934663
GSM549128patient 025, cancer, homogenized [OPG study]6.5031165
GSM549103patient 117, normal, homogenized [OPG study]6.6753568
GSM549117patient 073, normal, homogenized [OPG study]6.2820463
GSM549138patient 041, cancer, homogenized [OPG study]7.042671
GSM549141patient 045, cancer, homogenized [OPG study]7.201173
GSM549130patient 028, cancer, homogenized [OPG study]6.0541459
GSM549101patient 111, normal, homogenized [OPG study]6.4924265
GSM549105patient 128, normal, homogenized [OPG study]6.5853366
GSM549106patient 134, normal, homogenized [OPG study]7.2253773
GSM549112patient 048, normal, homogenized [OPG study]6.0302359
GSM549125patient 011, cancer, homogenized [OPG study]6.1432360
GSM549127patient 024, cancer, homogenized [OPG study]6.7435667
GSM549135patient 035, cancer, homogenized [OPG study]7.4698775